BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Nostrum Pharmaceuticals 



Basingstoke      United Kingdom
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical

Segment
Research





 Company News
Nostrum Pharmaceuticals Licenses Clinical Development and Worldwide Commercialization Rights From IMTECH, India for Novel, Next-Generation Thrombolytics With Clot Specific Activation and Re-occlusion Prevention Properties 11/29/2010 6:44:21 AM    More...
Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From IMTECH for Clinical Development of the Small Molecule Caerulomycin and Its Proprietary Derivatives for Their Novel Indication of Immunosuppression 2/24/2009 9:43:15 AM    More...
Nostrum Pharmaceuticals Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 4/22/2008 8:28:12 AM    More...
Synovics Pharmaceuticals, Inc. (SYVC.OB) Announces the Settlement of all Legal Proceedings with Nostrum Pharmaceuticals., Dr. Nirmal Mulye and Anil Anand 8/7/2007 1:37:05 PM    More...
Nostrum Pharmaceuticals Obtains Worldwide Licensing Rights From Institute of Microbial Technology (IMTECH) For Clinical Development Of A Novel Clot Busting Therapeutic Protein 7/28/2006 10:17:28 AM    More...
Shire Pharmaceuticals Group plc (SHPGY) Release: CARBATROL(R) Paragraph IV Litigation Update 10/19/2005 5:11:39 PM    More...
Elite Pharmaceuticals, Inc. (ELI) Announces End Of Negotiations With Nostrum Pharmaceuticals 10/19/2005 5:11:09 PM    More...
Nostrum Pharmaceuticals Confident Regarding Outcome Of Shire Laboratories' Carbamazepine ER Litigation 10/19/2005 5:09:02 PM    More...

//-->